salvia samuelssonii/vähk

Link salvestatakse lõikelauale

Artiklid Kliinilistes uuringutes Patendid

Valige sortimise tüüp

14 tulemused

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Traditional Chinese medicine (TCM) and dendritic cells (DCs) activation/maturation One of the important approaches to successful cancer immunotherapy is generation of specific T cell responses by dendritic cells (DCs). DCs are the most potent antigen-presenting cells for naive T cells, because their

A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Anlotinib (AL3818) is a kind of innovative medicines approved by State Food and Drug Administration（SFDA:2011L00661） which was researched by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. Anlotinib is a kinase inhibitor of receptor tyrosine with multi-targets, especially for

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Anlotinib Hydrochloride is a kind of innovative medicines approved by State Food and Drug Administration（CFDA:2011L00661） which was developed by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. Anlotinib is a kinase inhibitor of receptor tyrosine with multi-targets, especially for

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Study design This prospective, multi-center, parallel, centrally randomized controlled trial was designed in accordance with the Consolidated Standards of Reporting Trials (CONSORT) and Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines, which is led by the

Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Tumor heterogeneity leads to a significant difference in the rate of response to drugs in patients with the same pathological type. According to the information, the current initial effective rate of domestic and foreign chemotherapeutic single drug is no more than 30%, even if treated with repeated

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Anlotibib (AL3818) is a kind of innovative medicines approved by State Food and Drug Administration（SFDA:2011L00661） which was researched by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.To compare the effects and safety of Anlotinib with placebo in patients with metastatic colorectal cancer

A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Hepatocellular carcinoma (HCC) is one of the most common malignances seen in different regions of the world. Surgical resection provides the best chance of cure for selected patients. However, we have long been perplexed by high rates of tumor recurrence, which is often the main cause of long-term

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

This is a Phase I/IIa, multicenter, open-label, dose-escalation study. The study will be conducted in 6 phases: "2B3-101 single agent dose-escalation phase", "a 2B3-101 with trastuzumab dose-escalation phase", "a Breast cancer brain metastases study-expansion phase","a Recurrent malignant glioma

Cisplatin Based Chemoradiation v.s Radiotherapy for Cervical Cancer and With Clinically Defined Good Prognosis

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

OBJECTIVES: Primary Objectives: •To examine if low-risk, as defined by clinical and radiological parameters, stage IB-IIB cervical cancer patients treated by cisplatin-based CCRT have greater toxicities but similar survival rate as those treated by RT alone. Secondary Objectives: •To conduct a

Development of Active Safety Surveillance System for Traditional Chinese Medicine

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Liitu meie
facebooki lehega

Herbal & Natural Medicine

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

Töötab 55 keeles
Taimsed ravimid, mida toetab teadus
Maitsetaimede äratundmine pildi järgi
Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
Lugege oma otsinguga seotud teaduspublikatsioone
Otsige ravimtaimi nende mõju järgi
Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel